Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Sumitomo Pharma Plunges on Public Offering Announcement, Dilution Concerns Weigh on Sentiment
Sumitomo Pharma to Raise Up to \116.4 Billion Through Public Offering
Sumitomo Pharma, Net Income Forecast for the Fiscal Year Revised Upward by 11%, Exceeded Record Profit Forecast
Sumitomo Pharma, Apr-Dec (Cumulative 3Q) Net Income Increases by 5.1 times, Oct-Dec Net Income Decreases by 84%
Sumitomo Pharma, Net Income Forecast for the Fiscal Year Revised Upward by 2.3 times, Highest in Four Terms
Sumitomo Pharma, Returning to Profitability This Year
Sumitomo Pharma, 69% Increase in Net Income for The Current Fiscal Year
Sumitomo Pharma, Last Fiscal Year Net Income Revised Upward by 48%
Sumitomo Pharma, The Current Fiscal Year Net Income Turns to Profit, Exceeds Expectations
Sumitomo Pharma Co., Ltd., July-September (2Q) Net Income Loss Widens